XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Cash collections from financial royalty assets $ 744,949 $ 1,151,635
Cash collections from intangible royalty assets 13,544 617
Other royalty cash collections 26,311 19,685
Distributions from equity method investees 13,396 16,267
Interest received 6,430 15,568
Development-stage funding payments - ongoing (500) (500)
Payments for operating and professional costs (60,521) (86,846)
Interest paid (78,971) (82,589)
Net cash provided by operating activities 664,638 1,033,837
Cash flows from investing activities:    
Distributions from equity method investees 4,965 34,767
Investments in equity method investees (6,971) (3,579)
Proceeds from available for sale debt securities 1,440 0
Proceeds from sales and maturities of marketable securities 0 24,391
Acquisitions of financial royalty assets (86,084) (601,705)
Milestone payments 0 (12,400)
Net cash used in investing activities (86,650) (558,526)
Cash flows from financing activities:    
Distributions to legacy non-controlling interests - Portfolio Receipts (87,608) (91,938)
Distributions to legacy non-controlling interests - other (32,011) (33,394)
Dividends to shareholders (93,805) (88,633)
Contributions from legacy non-controlling interests - R&D 88 279
Contributions from non-controlling interests - other 1,338 3,313
Net cash used in financing activities (211,998) (210,373)
Net change in cash and cash equivalents 365,990 264,938
Cash and cash equivalents, beginning of period 477,010 1,710,751
Cash and cash equivalents, end of period $ 843,000 $ 1,975,689